1. Home
  2. SBSW vs SYRE Comparison

SBSW vs SYRE Comparison

Compare SBSW & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D/B/A Sibanye-Stillwater Limited ADS

SBSW

D/B/A Sibanye-Stillwater Limited ADS

HOLD

Current Price

$12.13

Market Cap

7.6B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$95.16

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBSW
SYRE
Founded
2013
2013
Country
South Africa
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
8.5B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
SBSW
SYRE
Price
$12.13
$95.16
Analyst Decision
Buy
Strong Buy
Analyst Count
3
12
Target Price
$19.93
$85.08
AVG Volume (30 Days)
4.8M
795.7K
Earning Date
02-20-2026
05-08-2026
Dividend Yield
2.17%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$43.55
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.10
$14.51
52 Week High
$21.29
$110.18

Technical Indicators

Market Signals
Indicator
SBSW
SYRE
Relative Strength Index (RSI) 71.25 38.06
Support Level $11.03 $66.78
Resistance Level $12.37 $106.10
Average True Range (ATR) 0.30 4.57
MACD 0.19 -1.11
Stochastic Oscillator 79.47 12.26

Price Performance

Historical Comparison
SBSW
SYRE

About SBSW D/B/A Sibanye-Stillwater Limited ADS

Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other. Group operations are divided into two segments, South African Operations and International and recycling operations.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: